Sanofi India Ltd.

₹3,501.3

-93.7 (-2.6%)

SANOFI Share Price

Pharmaceuticals & Biotechnology

As on March 13, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 8,061 Cr

P/E Ratio25.67

Dividend Yield0.33 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	3,625.88	Bearish
10-DMA	3,737.33	Bearish
20-DMA	3,891.1	Bearish
50-DMA	4,003.76	Bearish
100-DMA	4,219.29	Bearish
200-DMA	4,859.35	Bearish

Historical Performance

1 Year

-37.3%

3 Years

-39.1%

5 Years

-57.9%

10 Years

-20.3%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Dec-2024	Dec-2023	Dec-2004	Dec-2003
Net Sales	20,132	19,961	7,427	6,566
Total Expenditure	15,229	15,090	5,114	5,029
Other Income	170	618	198	144
Operating Profit	5,073	5,489	2,511	1,681
Interest	15	17	1	2
Depreciation	367	365	188	191
Profit Before Tax	4,314	5,285	2,390	1,557
Consolidated Net Profit	4,133	6,029	1,560	1,046
Adjusted EPS	180	262	68	45

Compounded Sales Growth

10 Years:0.4

5 Years:-8.1

3 Years:-7.4

TTM:0.2

Compounded Profit Growth

10 Years:3.5

5 Years:-5.4

3 Years:-19.8

TTM:-3

Stock Price CAGR

10 Years:-2

5 Years:-15.7

3 Years:-15.2

TTM:-37.4

Return on Equity

10 Years:139.8

5 Years:207.7

3 Years:269.8

last year:136.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Dec-2024	Dec-2023	Dec-2004	Dec-2003
Share Capital	230	230	230	230
Total Reserves	7,681	9,239	4,310	3,233
Long-Term Borrowings	---	---	---	---
Total Non-Current Liabilities	12,084	11,529	209	160
Other Current Liabilities	445	314	578	599
Short Term Borrowings	---	---	---	---
Total Liabilities	46,791	47,029	6,056	4,957
Capital Work in Progress	181	133	29	145
Long Term Loans & Advances	13,246	12,332	---	---
Currents Investments	---	---	---	---
Short Term Loans and Advances	19,359	19,146	514	389
Total Current Assets	30,177	31,315	4,353	3,158
Total Assets	46,791	47,029	6,056	4,957
Adjusted Book Value	344	412	189	142

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 25.67, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -15.2%, indicating poor shareholder returns.
The stock carries a low beta of 0.4, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹5073 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹20132 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 628447.3

No. of Shares: 179 (Approx)

Performance:-37.2%

P/L: ₹-371552.7

NIFTY Performance: 3.4%

1 day Top Gainers